Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tryptamine Therapeutics ( (AU:TYP) ) has issued an update.
Tryptamine Therapeutics Limited has announced the cessation of certain securities, specifically options that expired without being exercised or converted. This cessation involves a total of 1.8 million options with varying exercise prices. The announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies.
More about Tryptamine Therapeutics
Average Trading Volume: 2,505,731
Technical Sentiment Signal: Buy
Current Market Cap: A$51.98M
For an in-depth examination of TYP stock, go to TipRanks’ Overview page.